Lindahl acts as legal advisor when Swedencare AB (publ) acquires the US company RxV ENTERPRISES Corp. with its fully owned subsidiary Rx Vitamins Inc. (together “Rx Vitamins”).
The purchase price for Rx Vitamins amounts to USD 23 million (approximately SEK 200 million) and consists of a cash amount of USD 18,4 million (approximately SEK 160 million) and an issue in kind of 95,542 shares in Swedencare to the seller upon closing, which took place on April 1, 2021.
Swedencare develops, produces, markets, and sells premium products on the global and fast-growing market for animal health products for cats, dogs and horses. Swedencare’s product groups are represented on approximately fifty markets around the world and are sold through subsidiaries in the Nordics, United States, France, Spain, Greece, Great Britain and Ireland and through an external distribution network. Swedencare’s share is listed on Nasdaq First North Growth Market with ticker SECARE.
Rx Vitamins was founded in 1998 and is dedicated to providing veterinarians with nutritional formulations designed to enhance pet patient outcomes. Rx Vitamin’s customers are primarily veterinarians buying directly or through a selected number of distributors in the US. Additionally, Rx Vitamins has international sales in selected markets and sells some products for the human market.
Lindahl’s team consisted of Johan Herrström, Pernilla Skoglösa, Pontus Söderberg, Axel Siesjö (M&A) and Christian Sundén (IP). Lindahl was assisted in the acquisition by Wiggin and Dana in New York, a member of the same global network as Lindahl, TerraLex.